Method of purifying TFPI and TFPI analogs

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7851433
APP PUB NO 20050037475A1
SERIAL NO

10753078

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

, (2) isolation of refractile bodies, (3) dissolution of the refractile bodies and refolding of the expressed TFPI or TFPI analog, (4) SP-Sepharose fast flow (FF) chromatography, (5) a first concentration and diafiltration step, (6) Q-Sepharose high (HP) performance chromatography, (7) butyl hydrophobic interaction chromatography (HIC), (8) SP-Sepharose HP chromatography, and (9) a second concentration/diafiltration step. Less than about 12% of the TFPI or TFPI analog molecules in such preparations are modified TFPI or TFPI analog species (i.e., oxidized, carbamylated, acetylated, deamidated, aggregated, or misfolded species).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NOVARTIS VACCINES AND DIAGNOSTICS INC4560 HORTON STREET EMERYVILLE CALIFORNIA 94608 UNITED STATES OF AMERICA

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bolesch, Douglas G Berkeley, US 2 17
Cowgill, Cynthia A Berkeley, US 3 37
Dorin, Glenn San Rafael, US 14 157
Gustafson, Mark E St. Charles, US 8 65
Inlow, Duane Alamo, US 8 246
Reifsnyder, David H El Cerrito, US 1 2
Riquelme, Patricio T Walnut Creek, US 3 2

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation